Self-monitoring in Type 2 diabetes: A randomized trial of reimbursement policy

Diabetic Medicine

Volumn 23, Issue 11, 2006, Pages 1247-1251

  Johnson, J A ^a,c   Majumdar, S R ^b   Bowker, S L ^c   Toth, E L ^b   Edwards, A ^d  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c INSTITUTE OF HEALTH ECONOMICS   (Canada)

^d UNIVERSITY OF CALGARY   (Canada)

Author keywords

Adult diabetes; Glycaemic control; Health policy; Self monitor blood glucose

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEALTH CARE POLICY; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOMES RESEARCH; PATIENT EDUCATION; PATIENT SELECTION; PRIVATE HEALTH INSURANCE; RANDOMIZED CONTROLLED TRIAL; REIMBURSEMENT; SELF CARE; SELF MONITORING;

AGED; ALBERTA; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT EDUCATION; PATIENT EDUCATION AS TOPIC; REIMBURSEMENT MECHANISMS;

EID: 33750192669     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2006.01973.x     Document Type: Article

References (27)

1. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Monitoring glycemic control. Can J Diabetes 2003; 27: S21-S23.
2. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2005; 28: S4-S36.
3. Owens D, Barnett AH, Pickup J, Kerr D, Bushby P, Hicks D et al. Blood glucose self-monitoring in type 1 and type 2 diabetes: reaching a multidisciplinary consensus. Diabet Primary Care 2004; 6: 8-16.
4. Reynolds RM, Strachan M. Home blood glucose monitoring in type 2 diabetes. BMJ 2004; 329: 754-755.
5. Coster S, Gulliford MC, Seed PT, Powrie JK, Swaminathan R. Self-monitoring in Type 2 diabetes mellitus: a meta-analysis. Diabet Med 2000; 17: 755-761.
6. Welschen LMC, Bloemendal E, Nijpels G, Dekker JM, Heine RJ, Stalman WA et al. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review. Diabetes Care 2005; 28: 1510-1517.
7. Kennedy L. Self-monitoring of blood glucose in type 2 diabetes: time for evidence of efficacy. Diabetes Care 2001; 24: 977-978.
8. Meier JL, Swislocki ALM, Lopez JR, Noth RH, Bartelbaugh P, Siegel D. Reduction in self-monitoring of blood glucose in persons with type 2 diabetes results in cost savings and no change in glycemic control. Am J Managed Care 2002; 8: 557-565.
9. Mitchell CG, Simpson SH, Johnson JA. The cost of blood glucose test strips in Saskatchewan, 1996: a retrospective database analysis. Can J Diabetes 2003; 27: 149-153.
10. Laupacis A. Inclusion of drugs in provincial drug benefit programs: who is making these decisions, and are they the right ones? CMAJ 2002; 166: 44-47.
11. Davidson MB. Counterpoint: self-monitoring of blood glucose in type 2 diabetic patients not receiving insulin: a waste of money. Diabetes Care 2005; 28: 1531-1533.
12. Meltzer S, Leiter L, Daneman D, Gerstein HC, Lau D, Ludwig S et al. 1998 Clinical practice guidelines for the management of diabetes in Canada. CMAJ 1998; 159 Suppl. 8): S1-29.
13. Guerci B, Drouin P, Grange V, Bougneres P, Fontaine P, Kerlan V et al. Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study. Diabetes Metab 2003; 29: 587-594.
14. Toobert DJ, Hampton SE, Glasgow RE. The Summary of Diabetes Self-Care Activities Measure: results from 7 studies and a revised scale. Diabetes Care 2000; 23: 943-950.
15. Bowker SL, Mitchell CG, Majumdar SR, Toth EL, Johnson JA. Lack of insurance coverage for testing supplies is associated with poorer glycemic control in patients with type 2 diabetes. CMAJ 2004; 171: 39-43.
16. Guirguis LM, Johnson JA, Farris KB, Tsuyuki RT, Toth EL. A pilot study to evaluate the role of pharmacists certified as diabetes educators in the community setting. Can J Diabetes Care 2001; 25: 266-279.
17. Peel E, Parry O, Douglas M, Lawton J. Blood glucose self- monitoring in non-insulin-treated type 2 diabetes: a qualitative study of patients' perspectives. Br J Gen Pract 2004; 54: 183-188.
18. Lawton J, Peel E, Douglas M, Parry O. 'Urine testing is a waste of time': newly diagnosed type 2 diabetes patients' perceptions of self-monitoring. Diabet Med 2004; 21: 1045-1048.
19. Ipp E, Aquino RL, Christenson P. Point: self-monitoring of blood glucose in type 2 diabetic patients not receiving insulin: the sanguine approach. Diabetes Care 2005; 28: 1528-1530.
20. Schwedes U, Siebolds M, Mertes G. Meal-related structured self-monitoring of blood glucose: effect on diabetes control in non-insulin-treated type 2 diabetic patients. Diabetes Care 2002; 25: 1928-1932.
21. Nyomba BLG, Berard L, Murphy LJ. Facilitating access to glucometer reagents increases blood glucose self-monitoring frequency and improves glycemic control: a prospective study of insulin-treated diabetic patients. Diabet Med 2003; 21: 129-135.
22. Jones H, Edwards L, Vallis TM, Ruggiero L, Rossi SR, Rossi JS et al. Diabetes Stages of Change (DiSC) Study. Changes in diabetes self-care behaviors make a difference in glycemic control: the Diabetes Stages of Change (DiSC) study. Diabetes Care 2003; 26: 732-737.
23. Murata GH, Shah JH, Hoffman RM, Wendel CS, Adam KD, Solvas PA et al. Intensified blood glucose monitoring improves glycemic control in stable insulin-treated veterans with type 2 diabetes. Diabetes Care 2003; 26: 1759-1763.
24. Davidson MB, Castellanos M, Kain D, Duran P. The effect of self-monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial. Am J Med 2005; 118: 422-425.
25. Soumerai SB, Mah C, Zhang F, Adams A, Barton M, Fajtova V, et al. Effects of health maintenance organization coverage of self-monitoring devices on diabetes self-care and glycemic control. Arch Intern Med 2004; 164: 645-652.
26. Heisler M. Glycemic self-monitoring and insurance coverage. CMAJ 2004; 171: 48-49.
27. Brown LC, Johnson JA, Majumdar SR, Tsuyuki RT, McAlister FA. Evidence of sub-optimal cardiovascular risk management in patients with type 2 diabetes mellitus and symptomatic atherosclerosis. CMAJ 2004; 171: 1189-1192.